IntelliCyt Corporation's high throughput flow technology is the first to enable screening suspension cells, beads, microbes and mixtures.
Accelerate to discover
Back to filter
Show all topics (10)
Related topics
Cytek LIVE Demo : introducing the new Autofluorescence (AF) Explorer in Spectroflo 3.2.1
Sep 25, 2023
In this webinar, Cytek will be covering the new features introduced in the newest SpectroFlo 3.2.1 software release and...
Educational webinar: Introducing MARS Platform for gentle cell separation
Sep 6, 2023
Join us for a webinar where we will introduce the new MARS Platform by Applied Cells, a...
Meet us in Prague this weekend (2.-5.9) at 12th International Conference of Analytical Cytometry
Aug 29, 2023
Meet ACCELA team at 12th International Conference of Analytical Cytometry 2.-5.9.2023 in Prague,
Aug 17, 2023
Register for an engaging webinar led by Naz Chaudary, Ph.D., and Research Technician, Alex Wang from the...
Optimizing Gene Expression with Bioluminescence & the piggyBac System
Aug 15, 2023
Discover how bioluminescence imaging & the piggyBac gene editing system optimize & track gene expression in mouse...
Cytek webinar: High Parameter Spectral Flow Cytometry for Tumor Immunology Research
Jul 28, 2023
High Parameter Spectral Flow Cytometry for Tumor Immunology Research: This webinar will be a guide for Designing,...
Webinar: Exploring Oncology applications with the WOLF G2 Cell Sorter and N1 Single-Cell Dispenser
Jun 19, 2023
This educational webinar invites you to explore the scientific capabilities and oncology applications of the...
Webinar recording: Multimodal tissue imaging and machine learning to advance precision medicine
Jun 2, 2023
Enjoy this recorded webinar to learn how the Orion spatial biology imaging platform was used to identify prognostic...
Evaluating immunotherapeutic approaches for immuno-oncology using the iQue screener - June 17, 2016
Jun 13, 2016
Friday, June 17th, 2016, 5 pm CEST.
High content functional assays that can monitor parameters such as membrane integrity, cytokine release, and more, are critical to understanding target cell response to immunotherapies and allow for rational design of improved therapies.
This webinar will highlight:
- Challenges posed by current methods to screen the efficacy of immunotherapies.
- The need for high content robust tools to evaluate current immunotherapeutic approaches such as adoptive cell therapy, checkpoint blockade etc.
- The ability of the iQue Screener platform to acquire single-cell data on multiple biological readouts in a quantitative, high-throughput fashion and better understand functional efficacy of immuno-oncology therapies.
Related technologies: HTP Screening
Get more info
Brand profile
